by healthadvances Posted on May 3, 2018April 15, 2020 Patient Advocacy Groups as a Strategy for Orphan Drug Access in the UK Read More
by healthadvances Posted on April 10, 2018April 15, 2020 PCSK9 Inhibitors’ Battle for Reimbursement: Germany’s Decision and Implications in Other Countries Read More
by healthadvances Posted on March 22, 2018April 15, 2020 Highlights of the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress Read More
by healthadvances Posted on March 14, 2018April 15, 2020 Seattle’s Journey to the Summit of Cancer Commercialization Read More
by healthadvances Posted on March 13, 2018April 15, 2020 The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies Read More
by healthadvances Posted on January 19, 2018April 15, 2020 PART 3: What’s Next in 2018? Advanced Therapeutics – Gene Therapy, CAR-T, and Microbiome Read More
by healthadvances Posted on January 16, 2018April 15, 2020 PART 2: 2018 Wildcards – Healthcare Regulation and Models of Care Read More
by healthadvances Posted on January 12, 2018April 15, 2020 PART 1: Reflections on 2017 – Biopharma Therapeutics Read More
by healthadvances Posted on November 13, 2017April 15, 2020 Who’s Really First in FDA Cleared Digital Therapeutics? Read More
by healthadvances Posted on October 24, 2017April 15, 2020 Beyond Traditional Drug Development: Leveraging Personalized Medicine Read More
by healthadvances Posted on February 15, 2017April 15, 2020 Towards a Treatment for the Next Big Liver Disease Read More
by healthadvances Posted on December 2, 2016April 15, 2020 Strategies to Best Capitalize Accelerated Pathways for Innovative Medicines in the 21st Century Read More
by healthadvances Posted on April 11, 2016April 15, 2020 Drug Price Increases-Undue Pricing Power or Supported by Competitive Marketplace? Read More
by healthadvances Posted on November 9, 2015June 14, 2022 Beyond Turing and Valeant- Why is Drug Pricing Such a Hot Issue? Read More
by healthadvances Posted on July 22, 2015April 15, 2020 How Much Longer Before Biopharma Embraces Remote Monitoring in Clinical Trials? Read More
by healthadvances Posted on July 14, 2015April 15, 2020 CAR-T: The Emperor’s New Clothes or The Second Coming? Read More
by healthadvances Posted on July 2, 2015April 15, 2020 Juno Therapeutics and Celgene Ink 10 Year Deal Read More
by healthadvances Posted on June 25, 2015April 15, 2020 Drug Pricing & Reimbursement at the Boston CMO Network Read More
by healthadvances Posted on June 23, 2015April 15, 2020 Health Advances at ADA: Industry Forum Panel “Embracing the Future of Open Data Sharing” Read More
